Nina Kelly

International Biotechnology Trust’s Ailsa Craig: Covid-19 and investing in property

Ailsa Craig is an investment manager at International Biotechnology Trust (IBT). Ailsa joined SV Health Investors, a specialist healthcare fund manager, in 2006, as IBT investment analyst before being promoted to investment manager in 2008. Prior to this, she worked at Baring Asset Management as a research analyst, covering pharmaceutical and biotechnology stocks, and for Insight Investment/Rothschild Asset Management in the Global/US investment team. 

Sanlam’s Penny Lovell: everyone needs a ‘runaway fund’

Penny Lovell is the CEO of the private client part of Sanlam UK’s wealth division. Prior to her current role, Penny was managing director at Rothschild and Fleming Family and Partners, and head of private client, marketing and distribution at Close Brothers Asset Management.

I’ve just started investing: here’s why the market sell-off has not put me off

If you are a fledgling investor, or were just about to dip your toe in the water, this is undeniably a scary time. As well as the terrible human cost of the coronavirus pandemic, you’ll be reading about various economists’ predictions for the worst global slump since the Great Depression and digesting a swathe of news about turbulent stock markets, furloughed staff, and rising unemployment.

Budget 2020: the winners and losers

Chancellor Rishi Sunak, who has been in the role for less than a month, unveiled his “coronavirus Budget” during a week in which shares suffered their biggest falls since the 2008 global financial crisis and the Bank of England made an emergency interest rate cut, cutting the base rate from 0.75% to a historic low of 0.25%.